Wearable medical device developer Current Health said today it won FDA clearance for its its wireless wearable patient monitor.
The Edinburgh, Scotland-based company’s wearable monitor tracks vital signs and is intended to provide extra information to clinicians to allow for earlier interventions.
Current touted the device as “the most accurate, all-in-one wireless wearable currently approved for use in the EU and the U.S.,” and added that its algorithms continuously analyze data along with relevant contextual patient data to provide actionable insights.
“The Mount Sinai Health System works with innovative and leading-edge companies like Current to support our commitment to providing world-class patient care. Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier,” Dr. Scott Lorin of Mount Sinai Brooklyn said in a press release.
The device is currently being used in post-acute settings with UK-based healthcare providers, the company said.
“At Current, we’re a small team of individuals committed to changing the world through proactive healthcare. Our team worked hard to get here, and it’s just the first step toward monitoring the health of every human being to identify sickness earlier with the goal of saving lives. Today, we’re in the hospital, tomorrow the home, and in the near future, we’ll be everywhere. We are just getting started,” CEO Christopher McCann said in a prepared statement.
The post FDA clears Current Health’s patient monitoring system appeared first on MassDevice.